CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigate Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
13,421 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0606

Sildenafil (Viagra)

Filed under Oral Tablets. The bureau holds 49 laboratory returns for this compound from 16 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

16 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Tianjin Finder Chemical TFCCASE #VI-2026-0693A510.09.910.014 Nov 202516 Apr 2026
HomopeptideCASE #VI-2026-0760A79.99.910.025 May 202625 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538A28.98.39.621 May 202621 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486A78.87.19.724 May 202624 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704A68.67.29.724 May 202624 May 2026
Royal PeptidesCASE #VI-2026-0264X28.57.29.821 May 202524 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284A27.86.78.924 May 202624 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594A67.66.88.924 May 202624 May 2026
Shenzhen Jiechuang TradingCASE #VI-2026-0292X17.37.37.314 Jan 202514 Jan 2025
Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498E46.45.27.613 Feb 202520 May 2026
ZhuoYan labCASE #VI-2026-0902X36.35.47.82 Apr 202525 May 2026
Alimo PeptideCASE #VI-2026-0524X15.75.75.713 Jun 202513 Jun 2025
HXNetCASE #VI-2026-0061X25.24.36.113 Feb 202524 May 2026
PeptidologyCASE #VI-2026-0520X15.05.05.017 Dec 202417 Dec 2024
Haikou Mingheng TechnologyCASE #VI-2026-0250X13.23.23.228 Mar 202528 Mar 2025
LOOKBiotechCASE #VI-2026-0807X10.00.00.017 Dec 202417 Dec 2024

Open any subject to view the batch-level evidence for Sildenafil (Viagra) alone.